CUAMC
SAGE
China Universal Asset Management Company’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
12,577
+245
| +2% | +$2.23K | 0.01% | 355 |
|
|
2025
Q1 | $98K | Sell |
12,332
-639
| -5% | -$5.08K | 0.01% | 356 |
|
|
2024
Q4 | $70.4K | Buy |
12,971
+1,229
| +10% | +$6.67K | 0.01% | 425 |
|
|
2024
Q3 | $84.8K | Buy |
11,742
+4,672
| +66% | +$33.7K | 0.01% | 366 |
|
|
2024
Q2 | $76.8K | Sell |
7,070
-4,484
| -39% | -$48.7K | 0.01% | 318 |
|
|
2024
Q1 | $217K | Buy |
11,554
+4,617
| +67% | +$86.5K | 0.03% | 279 |
|
|
2023
Q4 | $150K | Buy |
6,937
+5,406
| +353% | +$117K | 0.03% | 236 |
|
|
2023
Q3 | $31.5K | Buy |
1,531
+748
| +96% | +$15.4K | 0.01% | 263 |
|
|
2023
Q2 | $36.8K | Sell |
783
-26
| -3% | -$1.22K | 0.01% | 223 |
|
|
2023
Q1 | $33.9K | Buy |
809
+204
| +34% | +$8.56K | 0.01% | 180 |
|
|
2022
Q4 | $23.1K | Buy |
605
+49
| +9% | +$1.87K | 0.01% | 167 |
|
|
2022
Q3 | $22K | Buy |
+556
| New | +$22K | 0.01% | 152 |
|